Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 13,261-13,272 of 23,847
Drug study icon
CompletedNCT00882518

Quetiapine Fumarate for Schizophrenia

This study is completed in China. It is testing quetiapine Fumarate for Schizophrenia.

Multiple locations, including Hunan
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
China
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedEUCTR NCT00511277

Quetiapine for Schizophrenia

This study is completed in Germany. It is testing quetiapine for Schizophrenia.

In Göttingen
SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Germany
Sponsor
Georg-August-University Göttingen
Condition
Schizophrenia
Drug study icon
TerminatedNCT01467713

Ramelteon Sublingual for Bipolarity

This study was terminated in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for Bipolarity.

Multiple locations, including Birmingham
BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Takeda
Condition
Bipolarity
Drug study icon
TerminatedNCT01467700

Ramelteon Sublingual for depression

This study was terminated in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for depression.

Multiple locations, including Birmingham
Depression, BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Takeda
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT00481975

Rimonabant on Weight Loss and Frequency of Binge Episodes for Eating disorders

This study is completed in the United States, in France, in Switzerland, .... It is testing rimonabant on Weight Loss and Frequency of Binge Episodes for Eating disorders.

Multiple locations, including Bridgewater
Eating disordersDrugFrom 18 Years to 70 Years
Countries
United States, France, Switzerland, ...
Sponsor
Sanofi
Condition
Eating disorders
Drug study icon
CompletedNCT00034762

Risperidone Compared With Placebo for Schizophrenia

This study is completed. It is testing risperidone Compared With Placebo for Schizophrenia.

Location not clearly listed
SchizophreniaDrugOver 55 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2015-003867-13

S 47445 for depression

This study is completed in Hungary, in Finland, in Slovakia, .... It is testing S 47445 for depression.

In Hungary
DepressionOther
Countries
Hungary, Finland, Slovakia, ...
Sponsor
Institut de Recherches internationales Servier
Condition
Depression
Drug study icon
CompletedNCT00954122

SEROQUEL Extended Release (XR) for schizophrenia

This study is completed in Malaysia. It is testing SEROQUEL Extended Release (XR) for schizophrenia.

Multiple locations, including Johor Bahru
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Malaysia
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedNCT00081380

Seroquel Plus Mood Stabilizer for Bipolarity

This study is completed in the United States and in Canada. It is testing seroquel Plus Mood Stabilizer for Bipolarity.

Multiple locations, including Birmingham
BipolarityDrugOver 18 Years
Countries
United States, Canada
Sponsor
AstraZeneca
Condition
Bipolarity
Drug study icon
CompletedNCT03325881

SHP465 at 6.25 mg for ADHD

This study is completed in the United States. 25 mg for ADHD.

Multiple locations, including Dothan
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.